`l_UCENTIS'
`RAN l S ! ZL.JMAS
`Business Use Only
`
`Lucentis PFS (RFB002)
`
`TRD SubTeam meeting
`
`Meeting Date: May 09 July 2012
`Meeting Notes Date: July 18, 2012
`Author:
`Room: WSJ-340.3 09
`Dial-in information:
`
`....
`
`T eleoorterences. m;g
`
`Team Members : (✓ = Present,* = part-time)
`
`Team Members : (✓ = Present,* = part-time)
`
`Executive Summary
`
`I
`I
`I
`
`I
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : July 09. 2012
`
`1 of 6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2080.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Agenda
`
`I
`
`•·
`I
`
`I I
`I ·-I
`
`-
`
`Minutes
`
`Pre-read
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date: July 09, 2012
`
`2 of 6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2080.002
`Regeneron v. Novartis, IPR2021 -00816
`
`
`
`I
`
`.L .
`
`I
`
`I I
`
`I I
`
`I
`
`I-
`I I
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : July 09. 2012
`
`3 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2080.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : July 09. 2012
`
`4 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2080.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`- 1111
`
`When
`
`Who
`
`- -
`
`-
`
`Action Plan
`
`What
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : July 09. 2012
`
`5 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2080.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date: July 09. 2012
`
`6 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2080.006
`Regeneron v. Novartis, IPR2021-00816
`
`